Teva Offers $149 Million for Nupathe, Outbidding Endo

Israeli pharmaceutical giant also reportedly in talks to acquire Korean biotech firm Celltrion.

Yoram Gabison
News Agencies
Send in e-mailSend in e-mail

Comments